RSHN (RushNet) Other Financing: $0.00 Mil (TTM As of . 20)


What is RushNet Other Financing?

RushNet RSHN -99.00% Other Financing is $0.00 Mil as of . 20.

RushNet's Other Financing for the three months ended in . 20 was $0.00 Mil.

RushNet's Other Financing for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.


RushNet Other Financing Historical Data

* Premium members only.

The historical data trend for RushNet's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RushNet Other Financing Chart

RushNet Annual Data
Trend
Other Financing

RushNet Quarterly Data
Other Financing

RushNet Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.00 Mil mean?
RushNet (RSHN) has a Other Financing of $0.00 Mil as of . 20. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for RushNet and its competitors.
Is RushNet's Other Financing too high?
RushNet's current Other Financing is $0.00 Mil.
How does RushNet's Other Financing compare to MOJO and LBIX?
RushNet's Other Financing of $0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Diagnostics & Research company?
A good Other Financing depends on the Medical Diagnostics & Research industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for RushNet and its competitors. RushNet's current Other Financing is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RushNet stock overvalued right now?
RushNet (RSHN) has a current Other Financing of $0.00 Mil. The current Other Financing is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For RushNet (RSHN), the current Other Financing is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RushNet Business Description

Address 8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222
RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians with individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments and the latest software for patient and physician satisfaction. It allows heliosDX to provide physicians with fast and accurate reporting meetings. The firm excels in patient and client care through physician-designed panels that aid in testing compliance and reporting education.